期刊文献+

乳腺癌循环肿瘤细胞研究进展 被引量:2

原文传递
导出
摘要 随着生物技术的不断发展,循环肿瘤细胞(CTC)现象的普遍性和重要性在肿瘤临床实践中逐渐得到重视,现已成为乳腺癌患者生存时间和生存率的优秀评测指标之一,对临床化疗药物开发和肿瘤疫苗的发明也可以起到推动和加速作用。本文回顾了CTC现象的发现历史,检测技术的发展及其在乳腺癌的应用现状和前景。
作者 廖宁 张国淳
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第32期2291-2295,共5页 National Medical Journal of China
基金 基金项目:广东省科技计划基金(20078030703011) 广东省自然科学基金(815008004000014)
  • 相关文献

参考文献53

  • 1Seronie-Vivien S,Mery E,Delord J,et al.Carcinocythemia as the single extension of breast cancer:report of a case and review of the literature.Ann Oncol,2001,12:1019-1022.
  • 2Ashworth T.A case of cancer in which cells similar to those in the tumours were seen in the blood after death.Aust Med J,1969,14:146.
  • 3Carey R,Taft P,Bennett J,et al.Carcinocythemia (carcinoma cell leukemia).An acute leukemia-like picture due to metastatic carcinoma cells.Am J Med,1976,60:273-278.
  • 4Engell H.Cancer cells in the circulating blood:a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation.Ugeskr Laeger,1955,117:822-823.
  • 5Roberts S,Watne A,McGrath R,et al.Technique and results of isolation of cancer cells from the circulating blood.AMA Arch Surg,1958,76:33,4-346.
  • 6Guller U,Zajac P,Schnider A,et al.Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.Ann Surg,2002,236:768-775.
  • 7Pelkey T,Frierson H,Bruns D.Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors.Clin Chem,1996,42:1369-1381.
  • 8Israeli R,Miller Jr W,Su S,et al.Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells:comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.Cancer Res,1994,54:6306-6310.
  • 9Ghossein R,Bhattacharya S,Rosai J.Molecular detection of micrometastases and circulating tumor cells in solid tumors.Clin Cancer Res,1999,5:1950-1960.
  • 10Braun S,Pantel K,Muller P,et al.Cytokeratin-positive cells in the bone marrow and survival of patients with stage Ⅰ,Ⅱ,or Ⅲ breast cancer.N Engl J Med,2000,24:525-533.

同被引文献43

  • 1Kim HJ, Park CI, Park BW, et al. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ andinvasive ductal carcinoma of the breast. Yonsei Med J, 2006,47: 333-342.
  • 2Badruddoja M. Micrometastasis and axillary dissection in breast cancer. Arch Surg,2010 ,145:1022-1023.
  • 3Wu CY, Wu MS, Chen YJ, et al. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer, 2007,43:799-808.
  • 4Bhuvarahamurthy V, Kristiansen GO, Johannsen M, et al. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMI~, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma. Oncol Rep,2006,15:1379-138g.
  • 5Kenny HA, Lengyel E. MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle ,2009,8:683-688.
  • 6Leppa S, Saarto T, Vehmanen L, et al. A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res,2004,10 : 1057- 1063.
  • 7Chen Y, Zou TN, Wu ZP, et al. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer. Int J Biol Markers,2010,25:59-68.
  • 8ASWORTH T R. A case of cancer in which cells similar to those in tumors were seen in the blood after death [J]. Aust Med J, 1869, 14: 146- 149.
  • 9LIU M C, SHIELDS P G, WARREN R D, et al. Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer [J]. J Clin Oncol, 2009, 27(31): 5153-5159.
  • 10JEMAL A, BRAY F, CENTER M M, et al. Glohal cancer statistics [J]. CA Cancer J Clin, 201 1, 61 (2): 69-90.

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部